Background This study determined annual prevalence and incidence trends of asthma among children in Taiwan Methods A random sample was selected for a population-based study with a selection probability of 0.5 from all 3-18 years insurants. The annual prevalence and incidence of asthma were estimated according to age, sex, insurance premium and degree of urbanization. 
Introduction
Asthma is a chronic, inflammatory lung disease characterized coughing, wheezing, dyspnea and chest tightness. 1 The prevalence of asthma varies worldwide. 2 Taiwan has characteristics of high humidity, subtropical climate, densely populated with air pollution and is undergoing rapid economic development. Prevalence of childhood asthmas in Taiwan has increased dramatically, from 1.3% in 1974 to 5.07% in 1985 and 5.8% in 1991. 3, 4 Childhood asthma has become a major health priority. Research on prevalence of childhood asthma in Taiwan is insufficient. Most previous prevalence estimates in Taiwan are either based on outdated data or small populations with limited nationwide representativeness. 5 -8 In addition, they almost all used questionnaires. Hence, the estimates might be limited by validity of diagnosis, misinterpretations in different populations and recall bias. To our knowledge, there have been only two nationwide studies surveying prevalence of asthma in children in Taiwan. One was the International Study of Asthma and Allergies in Childhood (ISAAC), which used questionnaires. 9 The other used a smaller sample size from National Health Insurance (NHI) database to estimate overall 8-year prevalence, not time-trend analysis. 10 In addition, no previous study has reported incidence of asthmatic children in Taiwan. Thus, more recent data based on large samples are needed to update the prevalence and incidence of asthmatic children in Taiwan.
In Asia, traditional Chinese medicine (TCM) has been used for centuries to treat asthma. Increasing scientific evidence supports the use of TCM for asthma, 11 -13 but only one nationwide study has examined the prevalence of TCM use for childhood asthma in Taiwan. 14 In our study, to provide more precise estimates, we used a substantially larger sample with a selection probability of 0.5 among children aged 3 -18 years between 2002 and 2008 in Taiwan to estimate the annual prevalence and incidence of asthma, as well as TCM use in newly diagnosed and prevalent cases. Epidemiological factors related to childhood asthma were also evaluated.
Methods

Data sources
The National Health Insurance Research Database (NHIRD) of NHI claims was used. The NHI program is a universal health insurance system and now covers 99% of 23.74 million residents of Taiwan. 15 This study used registry datasets for beneficiaries, for outpatient care by visits and for inpatient care by admissions. The dataset used in this study comprised a random sample of all children aged 18 years or younger, who were randomly selected with a probability of 0.5 from the entire population of the same age in NHRID dataset. Every individual has a unique personal identification number (PIN). All datasets can be interlinked through the PIN. Using PINs, comprehensive information on beneficiaries' demographic data, dates of clinical visits, diagnostic codes, details of prescriptions, expenditure amounts and other data on all selected children between 2002 and 2008 were retrieved from NHRID dataset. ICD-9-CM was used to identify diagnoses. Exclusion criteria discounted patients younger than 3 years. Datasets were released by NHIRI for research purposes. Data were analyzed anonymously, and the study was exempted from institutional review board approval of the Public Health, Social and Behavioral Science Committee Research Ethics Committee, China Medical University and Hospital, because this study analyzed existing data provided by governmental agency.
Ascertainment of diagnosed incident and prevalent cases
Claims datasets from 2000 to 2008 were searched to identify any outpatient visits or inpatient admissions with asthma diagnoses (ICD-9-CM code 493 or A-code A323). Patients were classified as having asthma and were included if they had at least three ambulatory claims with a diagnosis of asthma, or at least one inpatient claim with asthma as one of the discharge diagnoses during that specific year. Claims datasets of 2000 -2001 were used to exclude those who had asthma before 2002 for identifying incident cases.
An incident case was ascertained after confirming that patient did not meet criteria of asthma in claims datasets of the specific calendar year prior to the first asthma diagnosis. Claims datasets contained all types of healthcare service since 1996. Thus, incident cases identified after 1 January 2002 had an asthma-free observation period of at least 6 years. Incident cases were ascertained until 31 December 2008. Patients remained as prevalent cases regardless of whether they had asthma diagnosis in subsequent calendar year, as long as they remained in the datasets.
Sociodemographic and urbanization levels of residential areas
Sociodemographic factors studied included age, sex and insurance premium. Age was categorized into four levels: 3 -5, 6-10, 11-15 and 16-18 years. Insurance premiums were categorized into two levels: insurance premium , median value, and insurance premium median value. Insurance premium was determined by salary. NHI covers TCM prescriptions only for outpatient care; therefore, only TCM ambulatory care was analyzed.
Residential areas of patients comprised 365 Taiwan townships and were classified into 7 levels of urbanization according to Liu et al. 16 Seven levels of urbanization were high-density urban area, medium-density urban area, newly developed area, general area, aging-society area, rural area and nondeveloped area.
Statistical analysis
Prevalence and incidence rates of patients clinically diagnosed with asthma from 2002 to 2008 were estimated. Annual prevalence rates according to age, sex, insurance premium and urbanization level were obtained by dividing the number of prevalent cases of asthma in NHI datasets by the total number of residents enrolled in NHI program in a given year. Annual incidence rates were estimated according to sociodemographic categories by dividing the number of newly diagnosed asthma cases by the total number of patients enrolled in NHI program who did not have asthma at the beginning of the year.
Prevalence and incidence rates of asthma diagnosed among populations in different calendar years were adjusted for age and sex differences by using a direct standardization method and by assuming populations of different calendar years had the same standard age and sex composition. Age and sex distributions of the study population for 2002 were selected as a standard population, and weights for groups aged 3-5, 6 -10, 11 -15 and 16 -18 years were 6.88, 17.08, 16.87 and 11.13%, respectively, for boys and 6.30, 15.67, 15.54 and 10.53%, respectively, for girls. Age-and sex-adjusted rates for each calendar year were then calculated by assuming each calendar year population had this standard population distribution, while retaining its own age-and sex-specific rates for each calendar year.
Multivariate Poisson's regression models were used to analyze trends in prevalence and incidence over time, while controlling changes in underlying age, sex, insurance premium and urbanization level distributions. The dependent variables were asthma prevalence and incidence (asthma ¼ 1; nonasthma ¼ 0), and categorical predictor variables were entered for year (2002 as reference), age group (3 -5 years as reference), sex (female as reference), insurance premium (insurance premium less than median values as reference) and urbanization level (high-density urban area as reference). If a time trend was observed, rates of change in prevalence were analyzed by replacing categorical variables for the calendar year with a continuous variable defined as time (in years). The product term of age group and time variables, age group variable multiplied by time variable, were added in the multivariate Poisson regression models as covariates to examine interaction between age group and time, as well as to investigate whether rates of change over time in prevalence or incidence over time differed across age groups. A statistically significant interaction between time and a given age group indicated that the rate of change in prevalence/incidence differed over time compared with reference age group (3 -5 years). (Table 1) . After direct standardization of the population, annual standardized prevalence rates, as well as the discrepancy between crude and standardized annual prevalence rates, increased over time. Prevalence of TCM use decreased from 1.16 to 0.59% in asthma-prevalent children. Higher annual asthma prevalence rates were observed in the group characterized by the following factors: male, higher insurance premium, high-density urban area and medium-density urban area. Annual prevalence rates increased from 11.52 to 14.86% among female and from 14.34 to 18.61% among male.
The number of annual incident cases of asthma increased from 19 705 in 2002 to 28 093 in 2005 ( Table 1 ). The mean age of incident patients was 6.61 years, with an SD of 3.03. The crude annual incidence fluctuated between 1.01 and 1.49. After direct standardization, annual incidence rates gradually increased from 2002 to 2005, and then fluctuated thereafter. TCM use rates in asthma-incident children decreased from 3.59 to 1.69%. Higher annual asthma incidence rates were observed in group characterized by following factors: 3 -5 years old, male, high insurance premium, high-density urban areas and medium-density urban areas.
After multivariate adjustment, asthma prevalence was significantly associated with age [relative risk (RR): 2.14, 95% confidence interval (CI): 2.13 -2.16; 2.77, 2.75 -2.79; 2.18, 2.17 -2.20 for age groups 6 -10, 11 -15 and 16 -18 years, respectively; Table 2 Significant interactions between time and age groups in annual prevalence rates and incidence rates were observed for both sexes (P , 0.001; Figs 1 and 2) . The largest annual increase in asthma prevalence rates was in 16 -18-year age group, and the highest annual prevalence rate was after 2007. 
Continued
Annual prevalence rate in 3 -5-year age group increased gradually over time. Annual prevalence rates in the 6 -10-year age group decreased gradually and then increased gradually after 2005. Conversely, annual prevalence rates in the 11-15-year age group increased gradually until 2005 and decreased gradually thereafter. Annual increase in asthma incidence was largest in the 3 -5-year age group, followed by 6-10-, 11 -15-and 16 -18-year age groups. Annual asthma incidence rates for both boys and girls in 3 -5-and 6 -10-year age groups increased gradually over time with a slight decrease in 2006.
Discussion Main findings of this study
This study revealed increases in both crude and standardized annual prevalence rates from 2002 to 2008. A 22.95% increase in prevalence occurred over a 7-year period in Taiwan (from 12.99% in 2002 to 16.86% in 2008). However, annual standardized incidence rates fluctuated throughout the period. This might be partly explained by superior asthma care with improved survival rates and effective preventive methods. In addition, our study also showed higher annual prevalence and incidence rates in high-density and mediumdensity urban area.
A 13.74% increase in prevalence in the 16 -18-year age group occurred over a 7-year period in Taiwan. During the same period, crude incidence rate did not exhibit a linear growth trend. Instead, it decreased slightly. These may be explained by improved asthma care and effective prevention. Increased incidence in 3 -5-year age group might be due to improved asthma diagnosis in young people.
The results showed only 0.59 -1.16 and 1.69 -3.59% TCM use in asthma-prevalent and asthma-incident children, respectively. TCM use in asthma-prevalent and asthma-incident children showed a decreasing linear trend. TCM use was higher in incident than in prevalent cases. Two possible explanations are suggested for divergent trends between the prevalence and incidence of asthma and TCM use in children. First, most parents in Taiwan use Western medical services as primary choice for their children. Chinese medical services are used only as secondary choice or for integrated therapy. Second, Montelukast was introduced in Taiwan in 2000 for Step 2 asthma treatment and might have influenced TCM use in asthmatic children.
What is already known on this topic
A previous nationwide study used the smaller NHI database for a sample of one million insurants to estimate overall The result was 15.7 -17.3% in male patients and 14% in female patients 10 ; however, the study was primarily focused on atopic dermatitis. The present large-samplesize study provided a time-trend analysis of annual prevalence and incidence rates across several sociodemographic subgroups and of TCM use for asthmatic children in Taiwan. A few studies have surveyed diverse populations worldwide to estimate asthma prevalence in children. 2, 17, 18 In general, prevalence found in studies in Asia and Europe is lower than in regions that are more economically developed, and Taiwan is among the countries with high asthma prevalence. In this study, prevalence was higher than that reported for groups aged 6 -7 and 13-14 years in a similar period in Africa (3.4%; 10.8%), India (4.5%; 5.6%), Western Europe (9.7%; 15.8%), Northern and Eastern Europe (4.0%; 5.1%), Hong Kong (7.9%; 10.1%), Indonesia (4.8%; 12.4%), Seoul (9.9%; 5%), Kota Bharu (11.2%; 9%), Chiang Mai (6.1%; 9.9%) and Latin America (11.2%; 13.6%). Asthma prevalence was similar to that seen in Klang Valley (11.9%; 16.1%) and Bangkok (10.7%; 15.9%) but lower than those in North America (20.2%; 17.3%), Japan (23.0%; 19.9%), Oceania (29.2%; 22%) and Singapore (15.5%; 26.5%). 2, 17, 18 A possible explanation for higher prevalence in our study is that a considerably higher level of urbanization increased the prevalence of risk factors for asthma in children, such as air pollution, obesity, decreased physical activity and smoking.
Our study was descriptive, describing incidence and prevalence of asthma among various subgroups of children. In our study, prevalence was highest in 2008, among boys, among children aged 11-15 years, among children with medium insurance premium and among children living in a high-and medium-density urban area. Incidence was highest in 2005, among boys, among children aged 3-5 years, among children 
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with medium insurance premium and among children living in a high-density urban area. The current study showed that asthma is more common in boys, which has been explained by differences in lung/airway size and immunology. 19 -21 Asthma is more common and more severe in prepubertal boys, and males younger than 18 years of age have a higher rate of asthma than do females of the same age in the USA and Europe. 22, 23 Furthermore, residents of urban areas are more likely to have asthma than those of rural areas. Early exposure to microbes in rural areas might play a role in modulating immune system, thus reducing risk of asthma and allergies. 24 In addition, pollutants, cockroaches, mouse allergens, stress and development of obesity in urban environment might exert adverse effects on children's respiratory health. 25 Results of this study showed higher annual prevalence and incidence rates in high-density urban area and medium-density urban area groups, thus supporting findings of previous studies.
In Taiwan, only one study has been conducted on prevalence of TCM use in asthmatic children. Their results showed that 57.98% of asthmatic children had used TCM in Taiwan  from 2002 to 2010. 14 The reasons for higher usage than ours were their using period prevalence and estimating prevalence of TCM use not specifically for treating asthma in that study.
What this study adds
First, this study provides more precise prevalence and incidence estimates because of its very large sample size, which was selected from nationwide data through random sampling with a 0.5 selection probability. The NHI program in Taiwan provides insurance coverage for the entire population, which eliminates selection bias. In addition, the Bureau of National Health Insurance has contracted with 97% of all hospitals and 92% of all clinics nationwide. The possibility of underestimating the number of outpatient visits or inpatient admissions for asthma is low. Thus, findings of the present study can be generalized to the general population of Taiwan. Besides, the large number of participants facilitated subgroupstratified analysis. Second, it provides annual prevalence and incidence rates across several sociodemographic subgroups, including sex, socioeconomic status, locale and age. Third, it examined current TCM use in asthma-prevalent and asthma-incident children in Taiwan. In our study, we estimated point prevalence, instead of period prevalence of TCM use for asthma. Importantly, prevalence of TCM use in our study was estimated specifically for treating asthma.
Limitations of this study
This study also had limitations. It depended exclusively on claims data, which might have been subject to intentional or unintentional disease misclassification. However, to increase validity, only patients who had at least three ambulatory claims or at least one inpatient claim with an asthma diagnosis were included. Prevalence and incidence rates might have been underestimated because of this. Finally, information on lung function, severity of asthma and values of laboratory tests were not available in claims database; thus, incorporating this information in the discussions on asthma prevalence and incidence was beyond the scope of this study.
Conclusion
Public health professionals are recommended to plan appropriate health promotion programs, such as allergen avoidance and asthma control education, particularly for boys, residents of areas with higher urbanization, and those with higher premium insurance. In addition, future studies based on larger sample sizes should be encouraged to examine the costeffectiveness of integrated Western -Chinese therapies in treating childhood asthma.
